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Abstract

Introduction

Calcium phosphate ceramics are used in bone surgery under different form s: dense or porous ceram ics as
bone substitute, thin ceramic coatings on metallic im plants as an osseointegration enhancer. Their degradation depends on their physico-chemical properties and
particularly on their chemical composition. Natural calcium phosphates o f bone are degraded by mononuclear
or multinuclear cells and the extracellular matrix induces
the differentiation of the degrading -cells. Hydroxyapatite, which is one of the most used calcium phosphates ,
is known as a low degradation material. However , the
histological analysis of implanted HA- materials both in
animals and in humans showed that a cellular degradation took place on th e surface of the material.

Hydroxyapatite (HA) ceramics are used daily in
human and an imal surgery under different for ms [31.
36]. This material is classified as a surface-active biomaterial [33]. It means that an interfacial bond is
formed between the material and the tissue in which it is
implanted . Calcium phosphate materials , currently used
in human surgery , are assumed by surgeons to be non or slowly degradable materials. Depending on its use ,
a degradation may be necessary to improve osseointegration [20].
HA - materials such as HA -coatings and macroporous-HA can be considered to have a chemical composi tion which is close to bone mineral [42]. All other characteristics are radically different. The macroporous
ceramic can be composed of a single calcium phosphate
phase . HA -coatings can contain other calcium phosphate
phases in their amorphous phase [61]. The size of the
crystallites of bone is much smaller than the size of
ceramic grains , and the structure and the texture of bone
and ceramics are totally different [51]. Despite these
differences , based on its close chemical composition to
that of the bone mineral , HA is assumed to be a biodegradable material.
The purpose of this article is to discuss some
observations made on HA ceramic degradation in a
biological environment.

Key Words: Calcium phosphate ceramics, hydroxyapatite, hydroxyapatite-coatings , macroporous ceramics ,
cell degradation , osteoclast, macrophage , remodelling ,
dissolution.

Calcium phosphate ceramics
Ceramic material can be defined as all solid materials which are neither metal nor organic. Ceramics are
heterogeneous material constituted by grains which are
assembled using a thermal process (sintering stage).
They can be used in the form of bulk or porous material
obtained by slip casting or machining. Moreover , thin
coatings of calcium phosphate ceramic on metal alloys ,
polymers and composites can be obtained by plasmaspraying of HA -powder. The characteristics of the ceramic will have a great influence on the resorption of the
material. Moreover , different calcium phosphates can
be used to manufacture bioceramics. The HA and the
,B-tricalcium phosphate (,B-TCP) are the most commonly
used. The choice between these two compounds depends
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Figure 1. X-ray diffraction patterns of: HA-powder before plasma-spraying (A) , and of the obtained HA -coating (B).
The peaks are broader after the plasma-spraying indicating the presence of an amorphous phase after the spray.

384

Cell-Degradation of HA-Ceramics
The porosity of the material determines the size of the
surface which is in contact with the body fluid. The surface in contact with the tissue depends also on the interconnection of the material pores . It is generally admitted that a pore diameter of more than 100 ,u m is necessary for bone ingrowth [30] depending on the volume of
the implanted ceramic. If the interconnection of the
pores is poor , the size of the exposed surface will be
smaller than if the pore connection is high.
The size and the shape of the grains obtained after
the sintering stage or plasma-spraying can vary and have
an influence on the amount of the surface of the crystalline phase exposed to the body fluids .

Degradation of bone calcium phosphate
Bone mineral of the adult is composed of an A
and AB carbonated non -stoichiometric apatite [42] . Nu cleation of carbonated apatite crystals within the bone
extracellular matrix can be due to the re moval of biological inhibitors , to interaction between Ca 2 + and calcium -binding proteins , or to apatite precipitation out of locally supersaturated calcium phosphate solution made by
body fluids inside some microdomains [4 , 27 , 45 , 58].
Bone mineral crystals are first formed either inside "the
holes" existing between the fibrils in the collagen bundle
or inside extracellular matrix vesicles synthesized by osteoblasts. The bone mineral nucleation taking place in side these organic compartments is an heterogeneous
secondary nucleation controlled by the molecules con tained inside these compartments. Subsequently , the
mineralization spreads out of the nucleation site throughout the extracellular matrix , this , making the bone an
organa- mineral composite.
A high degradation rate of the organa-mineral
composite constituting the bone tissue by bone cells is
already known in several pathological and physiological
processes. Osteoclasts [12 , 44] are known to resorb
bone tissue during remodelling phenomena which occur
during the life of the bone. Bone tissue is resorbed by
osteoclasts or giant cells , during Paget ' s disease . Some
forms of osteoporosis , idiopathic osteolysis , and hyperparathyroidism are also characterized by the presence of
many osteoclasts resorbing bone tissue. From the histological studies carried out in these pathologies, two distinct kinds of cells were shown to degrade bone tissue
and calcium phosphate mineral: osteoclasts and mononu clear cells [ 13]. Histological analysis of bone allograft
shows , in the same resorption sites , mononuclear cells,
giant cells, and osteoclasts.

Figure 2. Scanning electron micrograph of an HA ceramic surface showing the grains constituting the ceram ic . Small holes exist between th e grains (arrowhead s) ;
they are randomly distributed and not interconnected ,
constituting the microporosity of the ceramic . Bar =
50 ,urn .

on the solubility required for the material. HA is con sidered to be quite insoluble and {3 -TCP soluble when
tested in vitro .
Different phases can appear in the HA -ceramics
according to the sintering protocol adopted and the puri ty of the powder used to manufacture the ceramic.
{3-tricalcium phosphate ({3 -TCP) can appear during the
manufacturing process of HA-ceramics. An amorphous
phase , which has a Ca/P ratio identical to the Ca/ P ratio
of HA but which cannot be identified as HA by X-ray
diffraction , can also be found in HA -ceramic coatings .
These phases do not have the same solubility as pure
crystalline HA. The crystallinity of the ceramic is measured by X-ray diffraction (XRD) . The broadening of the
XRD pattern peaks after plasma-spraying is representative of the amount of amorphous phase in the ceramic.
Amorphous phase which can contain other calcium phosphate phases , such as {3- TCP or calcium oxide , is more
soluble than the crystalline phase [61] (Fig. 1).
The porosity of the material is often divided into
microporosity and macroporosity . The microporosity is
due to the small spaces existing between the grains of
the ceramic which were left by the shrinkage occurring
during the material diffusion process at the grain boundaries (Fig . 2) . They have a diameter of less than a few
micrometers and are not interconnected . The macropo rosity results from the shaping of the ceramic done in
order to obtain a bone tissue ingrowth inside the ceram ic . The macropores should be interconnected and have
a diameter of from 100 ,urn up to several millimeters.

Osteoclasts: Osteoclasts are multinucleated (2 to
50 nuclei) giant cells (20 to 100 ,urn). Once in contact
with the bone , the newly formed osteoclast begins to
erode a cavity of characteristic shape and dimension .
They have a central ruffled border with many cytoplasmic folds , surrounded by a clear zone where the cell is
closely attached to the bone surface , forming a temporary seal around the site of bone destruction [17]. Cell
attachment could be mediated by oligosaccharides [48] .
The chemical processes mediating bone resorption are
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numerous and complex. Dissolution of the mineral is
the main task of the osteoclast which produces biochemical changes that includes release of acid, particularly
lactic acid and citric acid [43], coupled with increased
synthesis and release of lysosomal enzymes and other
proteases [32]. Carbonic anhydrase, which hydrolyses
carbonate into proton and carbon dioxide, plays a role in
the acidification of the medium at the interface of bone
and osteoclasts. The ruffled border membrane contains
a protein identical to H+ -pump found in the lysosomal
membrane [7]. The decrease of the pH induced by the
proton-pump in the extracellular compartment facing the
ruffled border seems to be responsible for the bone mineral degradation. Lysosomal enzymes secreted in this
compartment could help to degrade the organic matrix.
Furthermore, collagen fibrils could be degraded by other
cells containing large amounts of collagenase such as osteoblasts [32] although osteoclasts could resorb the organic and inorganic components of bone as reported by
Blair er al. [9]. However , the digestion of the collagen
coating, existing on bone surface , by osteoblasts and lining cells could be necessary for osteoclast digestion of
bone [15]. Complement (C 3 ) adsorption on the exposed
mineralized bone surfaces could mediate the recruitment
of mononuclear preosteoclasts to this site [46]. Osteoclasts have been known for a long time to be involved in
relation with osteoblasts in the normal remodelling of
bone tissue. Osteoclast precursors may respond to specific humoral signals emanating from other bone cells
such as active osteob1asts , lining cells , or immune cells
synthesizing interleukin I a and {3 , tumoral necrosis
factor a and {3, and transforming growth factors a and
/3 [5 , 55].
Osteoclasts originate from hemopoietic tissue.
They derive from mononuclear phagocytes as precursors. They arise from a derivative of the hemopoietic
stem cell that can become committed specifically to osteoclast generation [ 14] . The separation between osteoclasts and macrophages or giant cells lineage could come
early [11]. Alternatively , it remains possible that osteoclasts could develop from mature mononuclear phagocyte
by induction of osteoclastic differentiation in the special
microenvironment of bone surface. Osteoclast phenotype has been well characterized and shown to express
many of the antigens of the monocyte-macrophage lineage [5]. Mononuclear cells identified in histological
sections of bone , applied to the bone surface , show a
similar immunophenotype to that of the multinucleated
osteoclasts [6] .
Marrow-derived giant cells express osteoclast-specific cell surface antigens when cultured with calvariae.
In the mesenchymal cell containing chorioallantoic membrane, intact bone matrix induced the formation of giant
cells that express osteoclast-specific antigens [54]. Demineralized matrix and matrix components such as type
I collagen, osteocalcin , osteopontin, osteonectin, bonederived growth factors, cartilage proteoglycan , hyal uronic acid , laminin, and fibronectin do not induce the
formation of giant cells expressing osteoclast markers

(antigen 121 F) on their membrane [54]. In the same
experiment, a culture medium, conditioned by chick
hatched calvariae , induced the formation of giant cells
having osteoclast markers from the culture of a monocyte or marrow mononuclear cell population. It showed
that the terminal stages of osteoclast differenti ation were
influenced by soluble factors found in the bone environment. Glowacki et al. [28] showed that osteocalcin-deficient bone particles were not associated with osteoclasts
when implanted subcutaneously in rats. However, in the
same experiment, it was shown that synthetic microcrystalline HA recruited multinucleated cells lacking the
osteoclastic features [28].
Thus , osteoclast recruitment at the bone contact
depends on specific or non-specific humoral signals and
factors emanating from bone extra cellul ar matrix
(ECM). However, ECM calcium phosphate materials
can have an influence on osteoclast recruitment mediated
by non -specific humoral signals such as C 3 adsorption on
the naked calcium phosphate surface .
Other cells: It is not clear whether macrophages
contribute directly to bone remodelling in v ivo . Evidence has been presented that cells of the mononuclear
phagocytic system are capable of bone resorption in various culture system. Cells of the mononuclear phagocytic system were shown to resorb implanted isogeneic
bone matrix on ani mal. These cells are also present at
the point of contact of bone tissue allograft i n humans.
Mononuclear cells could be responsible for the digestion
of the bone collagen [32] and a part of the erosion cavity
dug by the osteoclast [21]. It is unclear if these cells are
precursor cells having failed to fuse or resorbing monocytes [52] helping osteoclasts by the release of cytokines.
Furthermore, macrophages are interrelated with
osteoblasts and synthesize cytokines which are able to
regulate their activity [34, 56] .
Degradation of ectopic natural HA-crystals
Ectopic calcium phosphate crystals found in soft
tissues induce a cellular response involving phagocytic
cells . Calcium oxalate and dicalcium pyrophosphate deposits in soft tissues are surrounded by histiocytes and
giant cells [10] . HA-crystals, identical to the HA-crystals found in the human joint disease, having a di ameter
of between 0.1 and 5 ~-tm, induce prostaglandin E2 release by macrophages [2]. Apatite-containing particles
are frequently found in osteoarthritic joints. Hydroxyapatite has been reported to induce acute inflammatory
reaction in human skin [ 18] and synovitis after injection
into dog's knee joints [60]. Articular chondrocytes were
shown to secrete collagenase, protease , and prostaglandins E2 and F2 after phagocytosis of HA-particles.
Cheung et al. [16] showed that the phagocytosis
of HA-crystal found in osteoarthritic joint induced the
multiplication of synovial cells. These results were
attributed to the increase of cytoplasmic Ca 2 + suggested
by a degradation of the crystals once phagocytosed.
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{3- TCP was considered as slowly degraded.

However,
the biological effects of the HA on isolated cells related
to the release of Ca 2 + from the ceramic, shows that HA
is not absolutely stable and may be degraded in living
tissue. It is particularly interesting to know the factors
affecting the degradation of HA-coatings which are supposed, in some cases, to last as long as possible, once
implanted. Klein et al. [39] have demonstrated that the
solubility of coatings was much higher than sintered particles. Degradation of calcium phosphate coatings in a
buffered solution in vitro was shown for tetracalcium
phosphate , tricalcium phosphate and HA. Maxian et al.
[47] recently reported that a greater in vitro Ca 2 + dissolution , and a greater surface, physical, and chemical
changes were observed for poorly crystallized coatings
compared to amorphous coatings, suggesting that amorphous coatings could be more advantageous if coating
longevity is desired. This is not consistent with what
has been previously published [61]. When we investi gated the in vitro behaviour of animal cells grown at the
point of contact of HA -coating having different crystallinities, it was found that more Ca2 + dissolved from coatings having a low crystallinity (40-70%) compared to the
coating having a high crystallinity (100%) [25]. HAparticles were found inside cells grown on both poorly
and highly crystalline coatings . The highly crystalline
coatings induced a cytostatic effect. It is interesting to
note that a coating degradation was found in vitro and
during short periods of time for all the crystallinities
tested.

Degradation of hydroxyapatite-ceramics
Chemical, biochemical and biological evidence
of Hydroxyapatite-solubility: Hydroxyapatite is one of
the less soluble calcium-phosphates used as bone substitute materiaL The solubility phase diagram of the most
frequently used calcium phosphates as biomaterials
shows that although HA is the most stable phase under
many conditions, it becomes less stable than dicalcium
phosphate dihydrate (DCPD) if the solution is sufficiently acidic. Such ranges of acid pH are commonly found
in some cell compartments and particularly in cells responsible for the bone degradation. It is considered that
both the endocytic and exocytic vacuolar apparatus in
cells are maintained at low pH [3]. Endocytic vesicles ,
lysosomes, portions of the trans-Golgi apparatus, certain
acid-producing secretory vesicles, and the "resorption
chamber" of the osteoclast are low pH cell compartments. Using fluorescein -labelled dextran , pH values of
4. 7-4.8 were measured in macrophage lysosomes [57] .
Similar pH values were measured by Baron et al. [7] in
the extracellular resorption region of osteoclasts. A recent report showed that cultured fibroblasts phagocytosed HA -particles inside or in close proximity to their
acidic intracellular compartment identified by neutral red
uptake [24]. Alliot-Licht et al. [1], Kwong et al. [41],
and Orly et al. [53] have demonstrated that calcium
phosphate grains having a size less than 50 JLm can be
phagocytosed by several kinds of cells such as fibroblasts, osteoblasts, established osteoblast-like cell lines ,
synovial cells, and macrophages then degraded in intracellular vesicles. Subsequent to the internalization of
HA-particles , it has been observed that the growth rate
and DNA synthesis of osteoblast were significantly inhibited [1]. The HA-particle size was found by Evans
[22] to have an effect on the cytotoxicity of HA in vitro.
Finely ground powders of HA reduced the growth rate of
fibroblast line. The effect was dose-related and only occurred with small particles (3-7 JLm). A physical effect
could interfere with the cell growth. In particular, the
elevated surface at the point of contact of the cell culture
medium , when the ceramic powder was finely ground ,
could induce an ionic modification of the culture medium
responsible for the cytotoxicity of the ceramic as demonstrated by Hyakuna et al. [35]. However, these results
were not consistent with the work of Mitchell et al. [50]
who reported a mitogenic effect of a mixture of calcium
phosphate crystals (HA, calcium phosphate, and calcium
pyrophosphate dihydrate) on synovial cells. Surface
characteristics and solubility of the materials tested
could explain this difference. The increase in free cytosolic Ca 2+ concentration with a simultaneous release of
inositol(l ,4,5) triphosphate seems to be necessary for a
mitogenic effect [ 49]. This is consistent with the higher
mitogenicity of free Ca2 + compared with HA crystals as
reported by Praeger and Gilchrest [59]. Based on earlier
reports [36-38] published on the implantation of calcium
phosphate ceramic, HA-ceramics were supposed to be a
non- or slowly-degradable material in a biological environment. HA was considered as non-resorbable , and

Microscopic evidence of material degradation:
HA is used under different forms : dense, porous , powdered or thin coatings. Gomi et al. [29] showed that osteoclast-like cells resorb sintered synthetic hydroxyapatite in vitro and that the nuclearity of the resorptive cells
is influenced by the surface topography of the substratum. Koerten et al. [40] demonstrated that spray dried
HA-spheres were degraded when injected into the mouse
peritoneal cavity. Miiller-Mai et al. [51] showed the
microscopic degradation of HA-coating. Recently Basle
et al. [8) demonstrated that macroporous calcium phosphate elicited, at the ceramic contact, the recruitment of
a double multinucleated cell population, giant multinucleated cells and osteoclasts, having a resorption
activity. This result is not consistent with that obtained
by Glowacki et al. [28]; it could be due to the difference
in features chosen for osteoclast characterization.
We have been able to perform histological analyses of HA materials implanted in human and animal bone
in the form of coating or macroporous ceramics in order
to evaluate the material degradation in vivo.
Materials and Methods

Fifteen hip prostheses coated with plasma sprayed-HA coatings (characteristics given in Table 1) and
implanted for periods from 5 days up to three years
(Table 2) were retrieved post-mortem from patients deceased for reasons which were not directly related to the
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Table 1. Characteristic of the HA-coatings analyzed.
Plasma-sprayed
powder

more than 97%

Crystallographic
structure

Ca 10 (P0 4 ) 6 (0Hh, other compounds admitted: tricalcium
phosphate (traces), calcium
oxide (traces), amorphous phase

Crystallinity

60%

Coating thickness

150~-tm

Trace elements

As < 3 ppm; Cd < 5 ppm ;
Hg < 5 ppm; Pb < 3 ppm

Mechanical strength
(pull-out test)

35 MPa

at 25 kV. The degradation of the coating was measured
on sections of 5 HA-coated prostheses using an image
analysis system. The maximum and minimum coating
thickness was determined on sections made at three
levels on each prosthesis.
On thick sections of two HA-coated prostheses
implanted three weeks and one year, the prosthesis was
detached from the bone and treated with a 2% NaOCl
solution for 24 hours to remove the organic matrix adsorbed on the coating. They were dehydrated and goldpalladium coated , then they were observed in the SEM
at 25 kV.
Twenty macroporous HA ceramics composed of
pure HA (characteristics given in Table 3) were implanted into 9 mm holes drilled into the cortical bone of
the medium diaphysis of sheep femurs for periods from
one month up to ten months . Five other ceramics were
implanted for two months into defects made into the medium diaphysis of dog ' s ulnae . Once retrieved , the im plants were processed as described above for histological
analysis .

± 10%

± 50~-tm

Table 2. Extreme values of the thickness (in ~-tm) of
coating implanted for various period (thickness before
implantation : 100- 150 ~-tm).
implantation

Metaphysis

Middle

Diaphysis

12 months

99-220

50- 164

40-184

24 months

0-180
104-204

0- 188

43 months

0- 183
5 8-164

119- 163

1.5 months
7 months

104- 143
163- 137

123-182

164- 119

Table 3.
ceramics.

Results and Discussion
A decrease in the coating thickness was noted
after a few months of implantation (Table 2). This deg radation can appear after a few weeks of implantation
and was not dependent solely on time . The degradation
could be completed after a two years implantation period
or was non-detectable after three years. SEM observations of specimens , whose organic matter had been removed by NaoCl , showed that the surface of the one
year implanted coating was very rough (Fig. 3) compared to the surface of the three weeks implanted one
(Fig. 4). Higher magnifications made it possible to see
the crystals of the coating suggesting a dissolution of the
amorphous phase between the grains.
Grains also
showed some degradation marks on some of their facets
(Fig . 5) .
Multinucleated cells and mononuclear cells were
found at the coating contact point in all the sections examined except the sections taken from the prosthesis implanted for five days. These cells were located at the
coating contact in regions facing medullary cavities.
Most of them , after a few months implantation period,
had HA-grains included in their cytoplasm showing a
phagocytosis of calcium phosphate grains coming from
the coating (Fig. 6) . Several types of coating degradation could be described morphologically and were observed both by SEM or light microscopy on prostheses
coating implanted for a few months (5 months or more).
Several of these types could be observed on the same
prosthesis: a) coating having a non-altered thickness in
contact with multi - or/and mono-nucleated cells contain ing HA-particles (Fig . 7); b) coating that was of an altered thickness in regions facing medullary cavities although coating in contact with bone tissue is not altered
(Fig . 8) ; c) coating having an homogeneously degraded
thickness; and d) coating degraded regions invaded by
bone tissue (Fig. 9).

213-155

Characteristics of the macroporous HA -

Chemical composition

100% HA

Porosity

70%

Pore diameter

500- 1500 I-'m

Grain size

3~-tm

All pores interconnected
hip surgery . The femurs containing the HA-coated prostheses were cut into three parts which were fixed into a
4% formaldehyde solution into PBS (phosphate buffered
saline). They were dehydrated in alcohol solutions and
embedded into PMMA (polymethyl methacrylate). Twothree mm thick sections were made using a low speed
cooled diamond saw. They were re-embedded at the surface of a polystyrene block and polished until a 50-100
~-tm thickness. Sections observed using a light microscope were stained with a fuscin-toluidine solution after
etching the block in a 1% formic acid solution and a
20% methanol solution . Sections observed using scan ning electron microscopy (SEM) were stained with a silver methenamine solution [23]. Briefly , sections were
stained using a 1% silver methenamine solution (brought
to pH 9.6 with NH 4 0H) for 4 minutes in a microwave
oven at 20% power (2450 MHz). Sections were then examined using the backscattered mode of a SEM operated
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Figure 3. Scanning electron micrograph of a one year implanted HA-coated prosthesis in human. The organic phase
in this sample had been removed by using NaOCl. The coating surface (C) is rough suggesting that degradation
occurred during the implantation period. Bone trabeculae (B) are apposed on the coating surface. Bar = 550 ~m.
Figure 4. Scanning electron micrograph of a three weeks implanted HA-coated prosthesis. The organic phase in this
sample had been removed by using NaOCl. The surface is very smooth showing no degradation sign. Bar = 140 ~m.
Figure 5. High magnification scanning electron micrograph of the surface of the prosthesis shown in Figure 3. The
amorphous phase is resorbed and the grains constituting the crystalline phase of the coating are observed. Some of
these grains show resorption marks on some of their facets (arrowheads). Bar = 10 ~m.
Figure 6. Back-scattered electron micrograph of a silver methenamine stained section of aHA-coating resorption zone
(HA) of a two years implanted prosthesis.
Osteoclast and macrophages contains calcium-phosphate particles
(arrowheads). Ti: titanium alloy. Bar = 35 ~m.
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Figure 7. Light micrograph of a one year implanted
HA-coating (HA) which does not show any signs of resorption. Some osteoclasts (solid arrow) are at the
coating contact and contain HA particles (arrowhead).
Fuscin-tolu:dine stained section (printed in black and
white from a color micrograph). Bar = 100 ,urn.

A similar process of grain phagocytosis was
observed on pure HA crystalline ceramics implanted in
bone defects in dogs invaded by loose connective tissue.
Mononuclear cells were found at the contact point of the
ceramic surface. Some of these cells were filled with
many calcium phosphate grains located inside cell vacuoles filling the whole cytoplasm (Fig. 10). They were
located in close proximity to the ceramic, suggesting that
the solubilization occurs rapidly inside the vacuoles. No
morphological sign of cell damage was found. Marks of
cell resorption were found in the ceramic zones where
the cells were present. The same HA-ceramics implanted in an osseous site in sheep for periods ranging from
two months up to ten months and invaded by bone tissue
seemed both solubilized and cell resorbed (Fig. 11).
Solubilization took place in the surface region in contact
with body fluid (in the medullary cavity), and cell resorption took place both in the regions at the bone contact point and in the regions previously partially solubilized. Solubilized regions were identified, on histological sections observed using backscattered electron mi croscopy as a less dense zone located on the material
surface surrounding a dense core of ceramic. The decrease of density was attributed to resorption occurring
at the grain boundaries. The evidence of cell resorption
of these ceramics was found in some regions where the
structure of the ceramic was altered at the contact of
some multinucleated cells without HA-grains found in
their cytopl'asm. This suggested that there was a dissolution process before the grain phagocytosis . Although some evidence of cell mediated dissolution exits,
it is difficult to evaluate from this study , which part of
the material degradation is due to a solution-mediated
process and which part is due to a cell-mediated
dissolution.
These results were consistent with those published
by den Hollander et al. [19] who studied the degradation
of 45 Ca-labelled macroporous HA-ceramics. HA showed
a small decrease in the specific activity of the implant
suggesting a degradation of the material once implanted.
However , the lack of radioactivity in the adjacent bone
normally being an area of increased calcium metabolism,
indicated the restricted availability of the liberated 45 Ca
for neogenesis of bone tissue. The presence of particles
of high specific activity was noted in lymph nodes.
Thus , even HA-ceramics which do not contain an
amorphous phase are cell degraded both in vivo and in
vitro. HA-macroporous ceramics used in our observations had a very low microporosity ( < 2%) with very
small pores and could be considered as dense material at
the cell level. The molecular mechanism of HA-degradation once implanted can involve surface processes controlling the dissolution rate of HA-crystal and cell excretion of ions, enzymes and proteins modifying the crystal
environment. Although the molecular mechanisms ruling the mononuclear precursors of osteoclasts are not
known, they are influenced by some of the HA-ceramic
characteristic and could be indirectly involved in the HA
degradation process.

Figure 8. Back-scattered scanning electron micrograph
of a silver ethenamine stained section of a one year implanted prosthesis showing a decreased coating thickness
in the regi on facing a medullary cavity (HA). Some
cells of the medullary tissue have phagocytosed coating
debris (arrcwhead) . B: Bone . Bar = 150 J.Lffi.
Figure 9. Reflected light micrograph of a resorbed
coating reg1on of a one year implanted prosthesis . Bone
has grown inside the resorbed coating (arrowheads). B:
Bone, Ti: 1itanium alloy. Bar = 150 J.Lm .
Figure lO A. Back-scattered scanning electron micro graph of a ;ilver methenamine stained section of a soft
tissue invaced macroporous HA-ceramic (HA) showing
resorption 2ones at the implant surface (hollow arrows).
Cytoplasm Jf mononucleated cells is filled with calcium
phosphate Erains (arrowheads) identified by energy dis persive X-ny spectroscopy . Bar = 40 J.Lm.
Figure lOE . Same area as in Figure lOA at a higher
magnificatim . Some cells are filled with calcium phosphate grain ; (sol id arrow) . Bar = 10 J.Lm.
Figure 11 . Back-scattered scanning electron micrograph
of a silver n ethenamine stained section of an HA-ceram ic (HA) imJlanted into bone (B) for two months . The
outside (so id arrow) region of the ceramic facing the
medullary cavity is less dense suggesting a dissolution of
the ceramic at the grain boundaries , although macrophages at tre ceramic contact contain HA particles. Bar
60 J.Lm.

TheS! micrographs showed that HA-coatings were
degraded W1en implanted into human bones and that the
degradatio was heterogeneous. HA -particles could be
released eitter by cell activity: osteoclasts acidifying the
resorption dlamber at the coating contact or by a dissolution procfSs of the amorphous phase as shown in vitro
[25]. However , the degradation rate of coatings having
the same craracteristics was not constant and other fac tors such a ~ the cytology of the implanted tissue should
be taken in o account.
A ccating remodelling process identical to the
bone remorelling process described by Frost [26] is suggested by t1e bone ingrowth into coating resorbed regions. Th e behaviour of bone at the coating contact
could be in·l uenced by protein factors released by coating degradi1g cells , and by a solution mediated process
involving tie release of Ca 2 + affecting cellular activity
or mineral >recipitation.
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articular chondrocytes stimulates release of collagenase,
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[17] Domon T , Wakita M (1991) The three-dimensional structure of the clear zone of a cultured
osteoclast. J Electron Microsc 40: 34-40
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(1982) Inflammatory responses to intradermal crystals in
healthy volunteers and patients with rheumatic diseases .
Rheumatol Int 2 : 55 -58 .
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Heidendal GAK (1991) Macroporous calcium phosphate
ceramics for bone substitution: a tracer study on
biodegradation with 45 Ca tracer. Biomaterials 12, 569573 .
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Radin S ( 1990) Effect of calcium phosphate coating
characteristics on early post-operative bone tissue ingrowth. Biomaterials , 11, 531-540.
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Reconstruction of the resorptive site in iliac trabecular
bone: a kinetic model for bone resorption in 20 normal
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[22] Evans EJ (1991) Toxicity of hydroxyapatite
in vitro: the effect of particle size. Biomaterials 12: 574576.
[23] Frayssinet P, Hanker J, Hardy D , Giammara
B (1991) Novel methods for demonstration osseointegration of hydroxyapatite-coated titanium hip prostheses.
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Press. pp . 34-35.
[24] Frayssinet P, Hardy D, Rouquet N,
Giammara B, Guilhem A, Hanker J (1992) New observations on middle term hydroxyapatite-coated titanium
alloy hip prostheses. Biomaterials 13: 668-674.
[25] Frayssinet P, Tourenne F, Rouquet N,
Giammara B, Bonel G (1992) Biological influence of
crystallinity of hydroxyapatite coatings for orthopaedic
use on cell growth . In: Thermal Spray: International
Advances in Coatings Technology Conference Proceedings. Brendt C (ed.). ASM International , Material Park ,
Ohio. pp. 477-486 .

Conclusions
Dissolution and cell degradation of synthetic HAceramic occur simultaneously and it is very difficult to
distinguish between them in vivo. We could not establish a rate of degradation of these ceramics since their
degradation is a very heterogeneous phenomenon. On
HA-coatings, the rate of degradation could vary on the
same prosthesis depending on the location where the
section was made. Also, depending on the tissue (e.g. ,
bone or bone marrow) in contact with the ceramic coating, the thickness of the coating facing these tissues is
not the same. Moreover, the resorption varies from one
patient to another.
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Editor's Note: All of the reviewer ' s concerns were ap propriately addressed by text changes , hence there is no
Discussion with Reviewers.
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